| Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis V Tzilas, E Bouros, I Barbayianni, T Karampitsakos, S Kourtidou, ... Pulmonary Pharmacology & Therapeutics 55, 17-24, 2019 | 89 | 2019 |
| The Autotaxin—Lysophosphatidic Acid Axis Promotes Lung CarcinogenesisThe ATX/LPA Axis Promotes Lung Carcinogenesis C Magkrioti, N Oikonomou, E Kaffe, MA Mouratis, N Xylourgidis, ... Cancer research 78 (13), 3634-3644, 2018 | 50 | 2018 |
| Metabolic disorders in chronic lung diseases O Papaioannou, T Karampitsakos, I Barbayianni, S Chrysikos, ... Frontiers in medicine 4, 246, 2018 | 42 | 2018 |
| Bleomycin revisited: a direct comparison of the intratracheal micro-spraying and the oropharyngeal aspiration routes of bleomycin administration in mice I Barbayianni, I Ninou, A Tzouvelekis, V Aidinis Frontiers in medicine 5, 269, 2018 | 39 | 2018 |
| MAP3K8 Regulates Cox-2–Mediated Prostaglandin E2 Production in the Lung and Suppresses Pulmonary Inflammation and Fibrosis M Zannikou, I Barbayianni, D Fanidis, T Grigorakaki, E Vlachopoulou, ... The Journal of Immunology 206 (3), 607-620, 2021 | 20 | 2021 |
| SRC and TKS5 mediated podosome formation in fibroblasts promotes extracellular matrix invasion and pulmonary fibrosis I Barbayianni, P Kanellopoulou, D Fanidis, D Nastos, ED Ntouskou, ... Nature Communications 14 (1), 5882, 2023 | 4 | 2023 |
| N-(2-Aminophenyl)-benzamide Inhibitors of Class I HDAC Enzymes with Antiproliferative and Antifibrotic Activity DT Gerokonstantis, C Mantzourani, D Gkikas, KC Wu, HN Hoang, ... Journal of Medicinal Chemistry, 2023 | 1 | 2023 |
| Increased lipocalin-2 expression in pulmonary inflammation and fibrosis A Galaris, D Fanidis, E Tsitoura, P Kanellopoulou, I Barbayianni, ... Frontiers in Medicine 10, 2023 | 1 | 2023 |
| Vitamin D predicts disease progression in patients with pulmonary fibrosis and blunts in-vitro fibrotic responses V Tzilas, A Tzouvelekis, E Bouros, T Karampitsakos, S Kourtidou, ... European Respiratory Journal 52 (suppl 62), 2018 | 1 | 2018 |
| MKP-5 inhibition blunts fibrotic responses in-vitro and in-vivo through negative regulation of TGFB1-induced smad3-signalling A Tzouvelekis, N Xylourgidis, K Min, T Karampitsakos, I Ninou, ... European Respiratory Journal 52 (suppl 62), 2018 | 1 | 2018 |
| Expression of PD-1/PD-L1 Axis and CD4/CD8 Ratio in Mediastinal Lymph Nodes of Human and Experimental Lung Fibrosis Indicates a Potential Therapeutic Target for Idiopathic … T Karampitsakos, A Galaris, S Chrysikos, O Papaioannou, I Vamvakaris, ... B65. IMMUNE AND ENDOTHELIAL CELLS HIT BACK AT LUNG REPAIR, A3956-A3956, 2023 | | 2023 |
| SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts T Karampitsakos, A Galaris, I Barbayianni, G DeIuliis, F Ahangari, ... Diagnostics 13 (6), 1166, 2023 | | 2023 |
| SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts T Karampitsakos, A Galaris, I Barbayianni, G DeIuliis, F Ahangari, ... Diagnostics 13 (6), 2023 | | 2023 |
| SRC-mediated and TKS5-enabled podosome formation is an inherent property of IPF fibroblasts, promoting ECM invasion and pulmonary fibrosis I Barbayianni, P Kanellopoulou, D Fanidis, ED Ntouskou, D Nastos, ... bioRxiv, 2023.01. 25.522705, 2023 | | 2023 |
| NOVEL N-(2-AMINOPHENYL)-BENZAMIDE INHIBITORS OF HDACs WITH ANTIPROLIFERATIVE AND ANTIFIBROTIC ACTIVITY C Mantzourani, DT Gerokonstantis, D Gkikas, KC Wu, HN Hoang, ... | | |
